biotech

Bio IPO Madness: Six Biotech Startups Raise $568M in 24 Hours
Bio IPO Madness: Six Biotech Startups Raise $568M in 24 Hours
Xconomy
biotech
IPOs
Eidos Therapeutics
Avrobio
XERIS
Aptinyx
Kezar Life Sciences
Magenta Therapeutics
Flag link:
Big Biotech Set for Earnings Blowout?
Big Biotech Set for Earnings Blowout?
Barron's
biotech
earnings
Gilead Sciences
Alexion
Vertex Pharmaceuticals
Flag link:
Former biotech analyst Jason Napodano sentenced to a short stretch in a federal prison for securities fraud
Former biotech analyst Jason Napodano sentenced to a short stretch in a federal prison for securities fraud
Endpoints
biotech
analyst
Jason Napodano
securities fraud
Flag link:
Biotech's Soon-Shiong hiring bankers for Nant cancer drug IPO
Biotech's Soon-Shiong hiring bankers for Nant cancer drug IPO
Reuters
biotech
IPOs
cancer
Nant
Patrick Soon-Shiong
Flag link:
Biotech Executives Fret Over Hassles And Uncertainties Of 'Right To Try'
Biotech Executives Fret Over Hassles And Uncertainties Of 'Right To Try'
Forbes
FDA
Scott Gottlieb
biotech
right-to-try laws
Flag link:
Topless women with company logos painted on their bodies danced at unofficial party during BIO convention
Topless women with company logos painted on their bodies danced at unofficial party during BIO convention
Stat
BIO 2018
biotech
Flag link:
AI And Biotech Companies In The East And West Invest In Combating Aging
AI And Biotech Companies In The East And West Invest In Combating Aging
Forbes
artificial intelligence
biotech
anti-aging
Insilico
AgeX
Flag link:
Scientists set out to build an ultra-fast camera to capture effect of new cancer drug tech
Scientists set out to build an ultra-fast camera to capture effect of new cancer drug tech
Endpoints
UK
biotech
cancer
devices
Flag link:
An Unlikely Biotech Investor: The Government
An Unlikely Biotech Investor: The Government
Forbes
biotech
BIO 2018
government
Flag link:
How women can empower themselves to close biopharma's gender pay gap
How women can empower themselves to close biopharma's gender pay gap
Medical Marketing and Media
women
gender gap
biotech
Flag link:
Relocating its US HQ to Boston, French pharma Ipsen to add 250 jobs
Relocating its US HQ to Boston, French pharma Ipsen to add 250 jobs
Endpoints
biotech
Boston
Kendall Square
Ipsen
hirings
Flag link:
Bill And Melinda Gates Start A Nonprofit Biotech In Boston
Bill And Melinda Gates Start A Nonprofit Biotech In Boston
Forbes
biotech
Bill Gates
Gates Foundation
non-profits
Boston
drug development
Flag link:
BIO18: Merck's Ebola lessons, New Jersey vies for biotech jobs
BIO18: Merck's Ebola lessons, New Jersey vies for biotech jobs
Biopharma Dive
Merck
ebola virus
New Jersey
biotech
BIO 2018
Flag link:
BIO18: Oncology surplus could drive down values
BIO18: Oncology surplus could drive down values
Biopharma Dive
biotech
M&A
Syneos Health
oncology
BIO 2018
Flag link:
Biotech’s Looming Talent Crisis: 5 Ways to Prepare for the Storm
Biotech’s Looming Talent Crisis: 5 Ways to Prepare for the Storm
Xconomy
biotech
human resources
executives
Flag link:
Biotech CEO Pay: Inflation Held At Bay
Biotech CEO Pay: Inflation Held At Bay
Forbes
biotech
executive pay
Flag link:
Incyte, Celgene and Vertex the best-paying companies–$ 215,000 per year (2017 average)
Incyte, Celgene and Vertex the best-paying companies–$ 215,000 per year (2017 average)
GoinPharma
biotech
salaries
Flag link:
3 Biotechs With Huge FDA Decisions in June
3 Biotechs With Huge FDA Decisions in June
Motley Fool
biotech
Array Biopharma
encorafenib
binimetinib
GW Pharma
Epidiolex
Incyte
olumiant
Flag link:
Biotech IPOs Roll On as Kiniksa, Scholar Rock Get $227M Combined
Biotech IPOs Roll On as Kiniksa, Scholar Rock Get $227M Combined
Xconomy
biotech
IPOs
Kiniksa Pharmaceuticals
Scholar Rock
Flag link:
Arch’s Bob Nelsen on Big Biotech and Why Pharma Should Be Very Afraid
Arch’s Bob Nelsen on Big Biotech and Why Pharma Should Be Very Afraid
Xconomy
Bob Nelsen
Arch Venture Partners
biotech
Flag link:

Pages